News | Cath Lab | February 27, 2018

NCDR CathPCI Registry Comes to Saudi Arabia

American College of Cardiology partnering with Saudi Arabian Cardiac Interventional Society to improve cardiac quality of care in the Middle East

February 27, 2018 — The American College of Cardiology (ACC) and the Saudi Arabian Cardiac Interventional Society have partnered to implement the NCDR CathPCI Registry in hospitals across Saudi Arabia. The CathPCI Registry assesses the characteristics, treatments and outcomes of heart disease patients who receive diagnostic catheterization as well as percutaneous coronary intervention procedures.

“Our National Cardiovascular Data Registry is a leading resource for hospitals and practices improving the quality of care they provide, and the ACC’s efforts to expand NCDR globally is in direct correlation with our mission to transform care and improve heart health,” said ACC President Mary Norine Walsh, M.D., FACC. “The Saudi Arabian Cardiac Interventional Society is a natural partner for this project as they lead efforts in the country to improve heart health in their communities.”  

The Saudi Arabian Cardiac Interventional Society is part of the ACC’s Saudi Arabia Chapter which is one of the largest and most active chapters with 141 members and a natural ally for this initiative, according to the ACC. Together, the two organizations aim to foster a culture of quality improvement in Saudi Arabian hospitals and this partnership represents a definitive step toward this joint goal.

In the initial phase of this collaboration, five hospitals have been selected to participate in a one-year pilot program of the CathPCI Registry. With the addition of these five hospitals, Saudi Arabia will have a total of seven active contributors to the CathPCI Registry, making it the first country outside of the United States capable of supporting a country-specific data benchmark. This benchmark would not only allow hospitals in Saudi Arabia to compare their performance to all other participating Saudi Arabian hospitals, it also lays the foundation for targeted cardiovascular research and partnerships between healthcare leaders throughout the region. Pending the success of the pilot program, the collaboration seeks to expand the network of Saudi Arabian hospitals contributing data to the CathPCI Registry. This would be the first country-wide, NCDR-based, quality improvement initiative project in the Middle East.

The five participating hospitals are:

  1. Suleiman Al-Habib Hospital, Riyadh
  2. Dammam Military Complex, Dammam
  3. King Fahd Armed Forces Hospital, Jeddah
  4. Suleiman Fageeh Hospital, Jeddah
  5. Care National Hospital, Riyadh

“The Saudi Arabian Cardiac Interventional Society represents all interventional cardiologists in the kingdom. Through this collaborative effort, the society hopes to standardize the level of care for coronary, structural and peripheral procedures to meet international benchmarks for safety and quality of care,” said Mirvat Alasnag, MB, BCh, SACIS international liaison. “In addition, we aim to utilize the database to identify areas for targeted improvement including STEMI, limb salvage, and valve procedures. It would also serve as a national database for research and strategic planning at a national level.”

This project is sponsored by Medtronic.

For more information: www.acc.org

Related Content

Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
Videos | Cath Lab | September 14, 2018
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS.
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Overlay Init